Genmab A (GMAB) Debt to Equity: 2019-2020
- Genmab A's Debt to Equity fell 15.62% to $0.02 in Q4 2020 from the same period last year, while for Dec 2020 it was $0.02, marking a year-over-year decrease of 15.62%. This contributed to the annual value of $0.02 for FY2020, which is 15.62% down from last year.
- As of Q4 2020, Genmab A's Debt to Equity stood at $0.02, which was down 15.62% from $0.02 recorded in Q4 2019.
- Genmab A's 5-year Debt to Equity high stood at $0.02 for Q4 2019, and its period low was $0.02 during Q4 2020.
- For the 2-year period, Genmab A's Debt to Equity averaged around $0.02, with its median value being $0.02 (2019).
- Data for Genmab A's Debt to Equity shows a maximum YoY fell of 15.62% (in 2020) over the last 5 years.
- Quarterly analysis of 2 years shows Genmab A's Debt to Equity stood at $0.02 in 2019, then declined by 15.62% to $0.02 in 2020.
